World Malaria Day 2017

World Malaria Day 2017

The 25th April is World Malaria Day and is an international opportunity for the global community to observe the infectious disease, that still affects millions of people worldwide.

Established by the World Health Organisation (WHO) in 2008, it marks the occasion to “highlight the need for continued investment and sustained political commitment for malaria prevention and control.”¹

Malaria is a deadly infectious disease, spread by vector to human via the female mosquito. Whilst detectable and treatable it’s still a disease that widely affects the undeveloped world where education around prevention is lacking and medicines for treatment are often scarce and expensive. 

Key Facts

  • Malaria means ‘bad air’4
  • Malaria is caused by a Plasmodium parasite spread by bites to humans, from infected mosquitos²
  • 3.2 billion people are at risk (in over 106 countries)³
  • It’s estimated (as many cases went unreported) that in 2013, 198,000 million cases occurred ¹

WHO have published a Global Strategy for Malaria 2016-2020, detailing a technical approach and guidance for countries affected, as well as organisations that can assist with the control of the disease.

By endorsing this strategy, WHO Members set out to achieve their vision of ‘a world free of malaria’ and ‘reducing the global malaria burden by 90% by 2030.’¹ This ambitious goal will be accomplished by scaling up malaria responses, increasing preventative methods including diagnostic testing and treatment. Innovation in this field and advances in research and development (R&D) remain to be a priority in eradicating the endemic infection.

BBI Solutions’ R&D teams have a wealth of experience in developing lateral flow assays for the detection of infectious diseases such as malaria and other bacterial/viral/parasitic clinical illnesses. In previous years BBI Solutions have donated rapid tests to the Robin Hood Clinic, Madagascar to conduct free testing of Malaria. If you have a question about developing a rapid diagnostic assay or about developing a lateral flow device, get in touch with our team today.

Alternatively, BBI also offer a wide range of products used for the in-vitro diagnostics market, for the discovery, treatment and hopefully the subsequent elimination of malaria. See below for our range of products.

Antigens

Patient Samples

Antibodies

Recommended matched pairs available

 

References

  1. Global Technical Strategy For Malaria (2016-2030), World Health Organisation 2015
  2. NHS, Causes of Malaria http://www.nhs.uk/Conditions/Malaria/Pages/Causes.aspx
  3. CDC, Malaria Facts https://www.cdc.gov/malaria/about/facts.html
  4. Borgen Project https://borgenproject.org/10-facts-malaria/


Copyright © 2017 BBI Solutions. All rights reserved. Designed trademarks and brands are the property of their respective owners. BBIUS